Suppr超能文献

肝素在兔腹膜间的转运。

Heparin transfer across the rabbit peritoneal membrane.

作者信息

Canavese C, Salomone M, Mangiarotti G, Pacitti A, Trucco S, Scaglia C, Assone F, Lunghi F, Vercellone A

出版信息

Clin Nephrol. 1986 Sep;26(3):116-20.

PMID:3769225
Abstract

Variable quantities of heparin have been proposed to avoid intraperitoneal clotting during peritoneal dialysis without the risk of systemic effects, because heparin is presumed to be incapable of passing through the peritoneal membrane. This study set out to verify this assumption by using labeled heparin in experimental dialysis in 7 New Zealand white rabbits. Heparin was labeled with 99mTc. Labeling quality, assessed by two chromatographic checks, showed less than 5% of free pertechnetate. Chromatographic determinations showed more than 95 and 80% of labeled heparin in inflow and outflow dialysates and in blood samples respectively. Following sodium thiopental anesthesia, animals underwent three protocols: a single 15 min cycle of time diffusion with heparin 500 U/l (A), 6 successive 15 min cycles with heparin 500 U/l (B), and a single 3 h cycle with heparin 2,500 U/l (C). Labeled heparin was found in blood organs and urine in variable percentages. The total amount of recovered radioactivity ranged from 1.5% (A) to 20% (C) of that introduced. It may be concluded that heparin passes through the peritoneum according to some law dependent on the amount used and the diffusion time.

摘要

有人提出使用不同剂量的肝素以避免腹膜透析过程中腹腔内凝血,同时避免全身效应风险,因为肝素被认为无法透过腹膜。本研究旨在通过在7只新西兰白兔的实验性透析中使用标记肝素验证这一假设。肝素用99mTc标记。通过两次色谱检查评估标记质量,结果显示游离高锝酸盐含量低于5%。色谱测定显示流入和流出透析液以及血液样本中标记肝素分别超过95%和80%。在硫喷妥钠麻醉后,动物接受了三个方案:一个使用500 U/l肝素的15分钟单次时间扩散周期(A)、六个使用500 U/l肝素的连续15分钟周期(B)以及一个使用2500 U/l肝素的3小时单次周期(C)。在血液、器官和尿液中发现了不同比例的标记肝素。回收放射性的总量占引入量的1.5%(A)至20%(C)。可以得出结论,肝素会根据所用剂量和扩散时间的某种规律透过腹膜。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验